PL3320901T3 - Dimetyloaminomicheliolid do zastosowania w leczeniu włóknienia płuc - Google Patents

Dimetyloaminomicheliolid do zastosowania w leczeniu włóknienia płuc

Info

Publication number
PL3320901T3
PL3320901T3 PL16887050T PL16887050T PL3320901T3 PL 3320901 T3 PL3320901 T3 PL 3320901T3 PL 16887050 T PL16887050 T PL 16887050T PL 16887050 T PL16887050 T PL 16887050T PL 3320901 T3 PL3320901 T3 PL 3320901T3
Authority
PL
Poland
Prior art keywords
dimethylaminomicheliolide
treatment
pulmonary fibrosis
fibrosis
pulmonary
Prior art date
Application number
PL16887050T
Other languages
English (en)
Inventor
Tao Sun
Yue Chen
Cheng Yang
Honggang Zhou
Huijuan Liu
Yanrong LIU
Jing Wang
Chengyu Zhang
Qiang Zhang
Xiangming Zhang
Yuan QIN
Xueshuang JING
Original Assignee
Accendatech
Tianjin International Joint Academy Of Biotechnology & Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Accendatech, Tianjin International Joint Academy Of Biotechnology & Medicine filed Critical Accendatech
Publication of PL3320901T3 publication Critical patent/PL3320901T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL16887050T 2016-01-28 2016-01-28 Dimetyloaminomicheliolid do zastosowania w leczeniu włóknienia płuc PL3320901T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16887050.9A EP3320901B1 (en) 2016-01-28 2016-01-28 Dimethylaminomicheliolide for use in the treatment of pulmonary fibrosis
PCT/CN2016/072445 WO2017128163A1 (zh) 2016-01-28 2016-01-28 含笑内酯二甲基胺的应用

Publications (1)

Publication Number Publication Date
PL3320901T3 true PL3320901T3 (pl) 2020-07-13

Family

ID=59397048

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16887050T PL3320901T3 (pl) 2016-01-28 2016-01-28 Dimetyloaminomicheliolid do zastosowania w leczeniu włóknienia płuc

Country Status (12)

Country Link
US (1) US10220019B2 (pl)
EP (1) EP3320901B1 (pl)
JP (1) JP6642892B2 (pl)
AU (1) AU2016390488B9 (pl)
CA (1) CA2995132C (pl)
DK (1) DK3320901T3 (pl)
ES (1) ES2783879T3 (pl)
HR (1) HRP20200473T1 (pl)
HU (1) HUE050456T2 (pl)
PL (1) PL3320901T3 (pl)
PT (1) PT3320901T (pl)
WO (1) WO2017128163A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11634400B2 (en) 2017-08-19 2023-04-25 University Of Rochester Micheliolide derivatives, methods for their preparation and their use as anticancer and antiinflammatory agents
EP4071143B1 (en) * 2020-03-26 2025-04-09 Accendatech Co., Ltd. Crystalline form of dimethylamino micheliolide fumarate monohydrate
WO2022041123A1 (zh) * 2020-08-28 2022-03-03 洛阳尚德药缘科技有限公司 倍半萜内酯类化合物在制备治疗视神经炎药物上的应用
CN113200949B (zh) * 2021-04-16 2022-11-29 天津大学 一种二甲胺含笑内酯-水杨酸盐及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA00011713A (es) * 2000-11-28 2002-05-31 Tgt Lab S A De C V Vectores recombinantes virales y no virales conteniendo el gen humano del activador de plasminogeno derivado de urocinasa y su utilidad en el tratamiento de diversos tipos de fibrosis hepatica, renal, pulmonar, pancreatica, cardiaca y cicatrices hipe
PL2562172T3 (pl) * 2010-04-23 2016-09-30 Pochodne sfelaktonu, ich kompozycje farmaceutyczne, sposoby wytwarzania i zastosowania
WO2012068299A2 (en) * 2010-11-16 2012-05-24 University Of Southern California Cbp/catenin antagonists for enhancing asymmetric division of somatic stem cells
AU2013394810B2 (en) * 2013-07-15 2018-05-10 Accendatech Uses of sesquiterpene lactone compound and derivative thereof in preparation of drugs
CN104418744B (zh) * 2013-08-29 2017-03-01 天士力制药集团股份有限公司 一种新的丹酚酸化合物t、其制备方法和用途
CN104876899A (zh) 2014-02-28 2015-09-02 天津尚德药缘科技股份有限公司 二甲胺含笑内酯富马酸盐及其用途
CN105520933B (zh) * 2014-09-29 2020-05-12 天津国际生物医药联合研究院 含笑内酯二甲基胺的应用

Also Published As

Publication number Publication date
EP3320901A1 (en) 2018-05-16
JP2019503335A (ja) 2019-02-07
HRP20200473T1 (hr) 2020-10-02
DK3320901T3 (da) 2020-05-11
JP6642892B2 (ja) 2020-02-12
AU2016390488B2 (en) 2019-12-12
US20190000798A1 (en) 2019-01-03
HUE050456T2 (hu) 2020-12-28
ES2783879T3 (es) 2020-09-18
EP3320901A4 (en) 2018-11-14
WO2017128163A1 (zh) 2017-08-03
PT3320901T (pt) 2020-04-24
AU2016390488B9 (en) 2020-09-17
CA2995132C (en) 2020-04-21
US10220019B2 (en) 2019-03-05
CA2995132A1 (en) 2017-08-03
AU2016390488A1 (en) 2018-03-01
EP3320901B1 (en) 2020-03-04

Similar Documents

Publication Publication Date Title
IL258002A (en) Cenicriviroc combination therapy for the treatment of fibrosis
IL247515A0 (en) Snekribirock for the treatment of leprosy
IL250960A0 (en) Combined treatment of sinecriviroc for the treatment of leprosy
IL266530A (en) Fibrosis treatment
SG11201607705XA (en) Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
PL3197472T3 (pl) Rekombinowane białka wolne od phe do stosowania w leczeniu fenyloketonurii
IL254142B (en) Tredifitant for use in the treatment of a disease or medical condition that responds to Tredifitent
PL3236960T3 (pl) Fluralaner do zastosowania w leczeniu demodekozy
PL3215157T3 (pl) Apilimod do stosowania w leczeniu czerniaka
IL250980A0 (en) Mucolytic agents for use in the treatment of pulmonary sarcoidosis
HUE054065T2 (hu) Szerek glióma kezelésében történõ alkalmazásra
SG11201607461PA (en) Polishing composition and polishing method using the same
HUE039750T2 (hu) Hidroxi-buspiron mozgászavarok kezelésére
IL253617A0 (en) Snekribirock for the treatment of leprosy
GB201423273D0 (en) The composite for eye care and its preparation method
IL246855A0 (en) Materials for use in the treatment of retinitis
HUE050456T2 (hu) Dimetil-amino-mikeliolid tüdõfibrózis kezelésében történõ alkalmazásra
HUE067036T2 (hu) 2-hidroxibenzilamin alkalmazása pulmonális magas vérnyomás kezelésében és megelõzésében
ZA201901099B (en) Compositions for the treatment of pulmonary fibrosis
IL267707A (en) Use of citrulline in reducing lung damage as a result of a bypass system for the heart and lungs
IL251840A0 (en) Use of femiroplast in the treatment of severe asthma
HUE044801T2 (hu) Adelmidrol alkalmazása epitheliális mûködési zavarok kezelésében
PL3020794T3 (pl) Kompozycja środka piorącego i jej zastosowanie
GB201407806D0 (en) Treatment of fibrosis
PL3439645T3 (pl) Stosowanie tamoksyfenu w leczeniu mukowiscydozy u pacjentów płci innej niż żeńska